Editas Medicine (EDIT) Amortizatization of Intangibles (2023 - 2024)

Editas Medicine's (EDIT) quarterly Amortizatization of Intangibles came in at $1.3 million in Q3 2024, up 6.34% year-on-year from $1.2 million in Q4 2023, and down 29.47% on a QoQ basis from $1.9 million in Q2 2024.

Editas Medicine (EDIT) Amortizatization of Intangibles (2023 - 2024) Analysis & Trends

Editas Medicine (EDIT) has 2 years of Amortizatization of Intangibles data on file, last reported at $1.3 million in Q3 2024.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Amortizatization of Intangibles (Qtr)
1 Oculis Holding AG 66,621.14 Bn 66,620.85 Bn - -
2 Nanobiotix 1,915.18 Bn 1,915.11 Bn - -
3 Akari Therapeutics 1,014.18 Bn 1,014.18 Bn - -
4 BeOne Medicines 471.27 Bn 466.48 Bn 1.35 Bn -
5 Vertex Pharmaceuticals 121.81 Bn 114.57 Bn 2.59 Bn -
6 Regeneron Pharmaceuticals 69.58 Bn 60.82 Bn 3.31 Bn -
7 Belite Bio 62.72 Bn 62.72 Bn - -
8 Argenx Se 55.51 Bn 50.33 Bn 1.41 Bn -
9 Revolution Medicines 37.35 Bn 37.35 Bn - 3.22 Mn
10 Editas Medicine 242.79 Mn 96.15 Mn - -

Historic Data

Download Data
DateValue
Sep 30, 2024 1.33 Mn
Sep 30, 2024 1.33 Mn
Jun 30, 2024 1.88 Mn
Jun 30, 2024 1.88 Mn
Mar 31, 2024 1.72 Mn
Mar 31, 2024 1.72 Mn
Sep 30, 2023 1.25 Mn
Sep 30, 2023 1.25 Mn
Jun 30, 2023 780,000.00
Jun 30, 2023 780,000.00
Mar 31, 2023 693,000.00
Mar 31, 2023 693,000.00